Epidemiological survey of bacterial meningitis in France in 1995-1997.

Citation
H. Dabernat et al., Epidemiological survey of bacterial meningitis in France in 1995-1997., MED MAL INF, 30(9), 2000, pp. 588-594
Citations number
30
Categorie Soggetti
Clinical Immunolgy & Infectious Disease
Journal title
MEDECINE ET MALADIES INFECTIEUSES
ISSN journal
0399077X → ACNP
Volume
30
Issue
9
Year of publication
2000
Pages
588 - 594
Database
ISI
SICI code
0399-077X(200009)30:9<588:ESOBMI>2.0.ZU;2-E
Abstract
Objective - We had for aim to confirm the therapeutical recommendations of the French Infectious Diseases Society, through an epidemiological study as sessing the incidence of various bacteria in primary bacterial meningitis, the susceptibility patterns for common species and the impact of Haemophilu s influenzae type b vaccine. Material and methods - We recorded the cases of acute purulent meningitis i n six French departments (total population 7.2 millions) between April 1995 and April 1997 Reference centers were defined in every department. They ha d to report all the cases (bacteria was isolated, either from the CSF; eith er from blood) occurring in their departments. Results - Two hundred and seven cases were recorded concerning patients ove r a month of age. Streptococcus pneumoniae and Neisseria meningitidis were the more frequent species (43% and 35.2% of the cases respectively) with an annual fetal incidence 0.75/100 000 and 0.63/100 000, respectively. S. pne umoniae was the predominant pathogen among adults and N. meningitidis among children between two and 19 years of age. 28% of S. pneumoniae s were less susceptible to penicillin and 19.5% were resistant 21% of N. meningitidis were less susceptible to penicillin. The other pathogenic bacteria were Lis teria monocytogenes (5.3%), Mycobacterium tuberculosis (4.4%), Escherichia coil (4.8%), Streptococcus agalactiae (3.4%), and Haemophilus influenzae(4. 8%). The annual incidence of H. influenzae meningitis is 0.08/100 000 for a il cases and 0.82/100 000 for cases in children under five years of age, il lustrating the impact of H. influenzae type b vaccine in our country (C) 20 00 Editions scientifiques et medicales Elsevier SAS.